PING-YANG L.

PING-YANG L.

Pharmacist

Followers of PING-YANG L.385 followers
location of PING-YANG L.Taiwan

Connect with PING-YANG L. to Send Message

Connect

Connect with PING-YANG L. to Send Message

Connect
  • Timeline

  • About me

    Medical Advisor at Pierre Fabre Taiwan

  • Education

    • 臺北醫學大學

      -
      Bachelor's degree Pharmacy GPA = 3.6

      活動和社團:Pharmaceutical Service Team Relevant Modules: Pharmacology, Pharmacotherapeutics, Pharmacokinetics, Taiwan Pharmacy Regulation.

    • UCL

      -
      Master of Science (MSc) Cancer Merit

      Relevant Modules: Cancer Clinical Trial, Immunotherapy, Cancer Biomarkers.Dissertation project: Exploring the associations between cancer fear, cancer stigma,and incorrect beliefs about cancer origin by using quantitative analyses in SPSS.

  • Experience

    • Taipei City Hospital - Women and Children Branch

      Oct 2014 - Feb 2016
      Pharmacist

      1. Monitored drug safety and Reported AEs to the government.2. Cooperated with interdisciplinary experts on improving internal workflow.3. Followed EBM approach to screening prescriptions and giving advice to doctors. 4. Made presentations on latest journal articles and case reports.5. Built up prudent working attitude: 0 dispensing error for continuous 9 months. 6. Built up strong team spirit: Actively assisted colleagues with their task.

    • Panco Healthcare

      Dec 2017 - Feb 2019
      Medical Science Liaison (Hematology)

      1. Communicated scientific information with Key Opinion Leaders (KOLs). 2. Performed market research and explored potential niches for current products. 3. Provided internal training for medical sales representatives. 4. Provided academic support for the commercial team. 5. Participated in study startup and monitored clinical trials.

    • Merck Gruppe

      Feb 2019 - Jul 2021
      Medical Science Liaison (Oncology/Immuno-Oncology )

      Award- Medical Leadership Award (regional)- 2020 H2 SHINE Recognition Award: Achievement (local)- 2020 H1 SHINE Recognition Award: Integrity (local)Launch preparation- Generated TEPMETKO launch plan and implement pre-launch activities (1 ABM and 3 seminars) - Constructed NSCLC ad-hoc EAP process in Taiwan (80% global approval rate)- Built UC patient flow and provided actionable insights for launch plan (regional project lead)Scientific Interaction - Established Taiwanese HNC expert consortium (3 projects collaborating with society)- Hosted seminars and provided speaker training (10 cross-country seminars and 1 MDT event)- Discuss clinical evidence with KTLs and gather real-world insight (30 engagements/month) Data Generation - Assess the potential and feasibility of ISS proposals (2 submissions with regional approval)- Manage publication projects (1 published, 1 under journal review, and 2 manuscript drafting) Reimbursement- Assisted with Bavencio MCC listing (achieve targeted listing price and waive PD-L1 testing) Regulatory Affairs- Prepared application dossier for fast-track designation (approved by Taiwanese FDA) Overseas Sponsorship- Implemented overseas sponsorship project (ESMO-Asia)- Generated external/internal post-congress materials (ASCO, ESMO, and ESMO-Asia) Cross-functional collaborations- Generated country brand plan (Erbitux 2020/2021 SCCHN CBP)- Delivered internal training (1 regional training)- Review promotional materials to ensure compliance with regulations (4 reviews/month) 收回

    • Bayer

      Dec 2021 - Oct 2022
      Medical Science Liaison (Oncology)
    • Pierre Fabre Group

      Oct 2022 - now
      Medical Advisor (Oncology)
  • Licenses & Certifications

    • International Driving Permit

    • Pharmacist License

      Taiwan GOV